Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease

American Heart Journal

Volumn 159, Issue 6, 2010, Pages 1044-1051

  Grandi, Norma Christine ^a   Breitling, Lutz Philipp ^a   Vossen, Carla Yvonne ^a   Hahmann, Harry ^b   Wüsten, Bernd ^c   März, Winfried ^d   Rothenbacher, Dietrich ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Klinik Schwabenland   (Germany)

^c Klinik Am Südpark   (Germany)

^d SYNLAB ACADEMY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FATALITY; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; REHABILITATION CARE; TREATMENT DURATION; VITAMIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; TIME FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77953182705     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.03.031     Document Type: Article

References (22)

1. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
2. Gouni-Berthold I., Krone W., and Berthold H.K. Vitamin D and cardiovascular disease. Curr Vasc Pharmacol 7 (2009) 414-422
3. Johnson R.C., Leopold J.A., and Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99 (2006) 1044-1059
4. Martins D., Wolf M., Pan D., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167 (2007) 1159-1165
5. Mattila C., Knekt P., Mannisto S., et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30 (2007) 2569-2570
6. Forman J.P., Giovannucci E., Holmes M.D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49 (2007) 1063-1069
7. Li Y.C., Qiao G., Uskokovic M., et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90 (2004) 387-392
8. Michos E.D., and Melamed M.L. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 11 (2008) 7-12
9. Maalouf N.M. The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hypertens 17 (2008) 408-415
10. Giovannucci E., Liu Y., Hollis B.W., et al. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168 (2008) 1174-1180
11. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 (2008) 503-511
12. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168 (2008) 1340-1349
13. Prentice A. Vitamin D deficiency: a global perspective. Nutr Rev 66 10 Suppl 2 (2008) S153-S164
14. Koenig W., Twardella D., Brenner H., et al. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51 (2005) 321-327
15. Rothenbacher D., Koenig W., and Brenner H. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med 166 (2006) 2455-2460
16. Koenig W., Twardella D., Brenner H., et al. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol 26 (2006) 1586-1593
17. Mathieu C., and Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol Med 8 (2002) 174-179
18. Rigby W.F., Denome S., and Fanger M.W. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 79 (1987) 1659-1664
19. Sauerbrei W., Meier-Hirmer C., Benner A., et al. Multivariable regression model building by using fractional polynomials: description of SAS, STATA and R programs. Comput Stat Data Anal 50 (2006) 3464-3485
20. Marniemi J., Alanen E., Impivaara O., et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis 15 (2005) 188-197
21. Melamed M.L., Michos E.D., Post W., et al. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168 (2008) 1629-1637
22. Lee J.H., O'Keefe J.H., Bell D., et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 52 (2008) 1949-1956